nodes	percent_of_prediction	percent_of_DWPC	metapath
Vecuronium—SLC22A1—ganglion—brain cancer	0.0571	0.111	CbGeAlD
Vecuronium—CHRNA1—endocrine gland—brain cancer	0.0286	0.0554	CbGeAlD
Vecuronium—CHRNA1—head—brain cancer	0.0282	0.0547	CbGeAlD
Vecuronium—CHRNB1—medulla oblongata—brain cancer	0.0275	0.0533	CbGeAlD
Vecuronium—CHRNB1—midbrain—brain cancer	0.0251	0.0487	CbGeAlD
Vecuronium—CHRNB1—spinal cord—brain cancer	0.0245	0.0475	CbGeAlD
Vecuronium—CHRNA2—endocrine gland—brain cancer	0.0237	0.046	CbGeAlD
Vecuronium—CHRNA2—head—brain cancer	0.0234	0.0454	CbGeAlD
Vecuronium—Myopathy—Temozolomide—brain cancer	0.0223	0.0461	CcSEcCtD
Vecuronium—SLC22A1—telencephalon—brain cancer	0.022	0.0427	CbGeAlD
Vecuronium—CHRNB1—head—brain cancer	0.0218	0.0422	CbGeAlD
Vecuronium—CHRNA2—central nervous system—brain cancer	0.0214	0.0414	CbGeAlD
Vecuronium—CHRNA2—cerebellum—brain cancer	0.0209	0.0405	CbGeAlD
Vecuronium—CHRNA1—brain—brain cancer	0.0205	0.0396	CbGeAlD
Vecuronium—Injection site pain—Carmustine—brain cancer	0.0198	0.041	CcSEcCtD
Vecuronium—CHRNB1—cerebellum—brain cancer	0.0194	0.0377	CbGeAlD
Vecuronium—CHRNA2—brain—brain cancer	0.017	0.0329	CbGeAlD
Vecuronium—Injection site reaction—Carmustine—brain cancer	0.0161	0.0333	CcSEcCtD
Vecuronium—Respiratory failure—Temozolomide—brain cancer	0.0159	0.0329	CcSEcCtD
Vecuronium—CHRNB1—brain—brain cancer	0.0158	0.0306	CbGeAlD
Vecuronium—Apnoea—Etoposide—brain cancer	0.0148	0.0305	CcSEcCtD
Vecuronium—ABCB1—blood vessel—brain cancer	0.0147	0.0284	CbGeAlD
Vecuronium—Face oedema—Hydroxyurea—brain cancer	0.014	0.029	CcSEcCtD
Vecuronium—SLC22A1—endocrine gland—brain cancer	0.0139	0.0269	CbGeAlD
Vecuronium—SLC22A1—head—brain cancer	0.0137	0.0266	CbGeAlD
Vecuronium—SLC22A1—central nervous system—brain cancer	0.0125	0.0243	CbGeAlD
Vecuronium—Flushing—Procarbazine—brain cancer	0.0121	0.0249	CcSEcCtD
Vecuronium—Face oedema—Carmustine—brain cancer	0.0113	0.0235	CcSEcCtD
Vecuronium—Face oedema—Temozolomide—brain cancer	0.011	0.0227	CcSEcCtD
Vecuronium—Muscular weakness—Carmustine—brain cancer	0.0104	0.0214	CcSEcCtD
Vecuronium—Muscular weakness—Temozolomide—brain cancer	0.01	0.0207	CcSEcCtD
Vecuronium—SLC22A1—brain—brain cancer	0.00994	0.0193	CbGeAlD
Vecuronium—Anaphylactoid reaction—Etoposide—brain cancer	0.00939	0.0194	CcSEcCtD
Vecuronium—Angiopathy—Hydroxyurea—brain cancer	0.00912	0.0189	CcSEcCtD
Vecuronium—Shock—Procarbazine—brain cancer	0.00908	0.0188	CcSEcCtD
Vecuronium—Tachycardia—Procarbazine—brain cancer	0.00901	0.0186	CcSEcCtD
Vecuronium—Erythema—Hydroxyurea—brain cancer	0.00875	0.0181	CcSEcCtD
Vecuronium—Hypotension—Procarbazine—brain cancer	0.00863	0.0178	CcSEcCtD
Vecuronium—Connective tissue disorder—Carmustine—brain cancer	0.00799	0.0165	CcSEcCtD
Vecuronium—Bronchospasm—Etoposide—brain cancer	0.00773	0.016	CcSEcCtD
Vecuronium—Connective tissue disorder—Temozolomide—brain cancer	0.00772	0.016	CcSEcCtD
Vecuronium—Flushing—Carmustine—brain cancer	0.00754	0.0156	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.0074	0.0153	CcSEcCtD
Vecuronium—Urticaria—Procarbazine—brain cancer	0.00733	0.0152	CcSEcCtD
Vecuronium—Flushing—Temozolomide—brain cancer	0.00729	0.0151	CcSEcCtD
Vecuronium—Cardiac disorder—Temozolomide—brain cancer	0.00729	0.0151	CcSEcCtD
Vecuronium—Angiopathy—Temozolomide—brain cancer	0.00713	0.0147	CcSEcCtD
Vecuronium—ABCB1—telencephalon—brain cancer	0.00711	0.0138	CbGeAlD
Vecuronium—Immune system disorder—Temozolomide—brain cancer	0.0071	0.0147	CcSEcCtD
Vecuronium—Mediastinal disorder—Temozolomide—brain cancer	0.00708	0.0146	CcSEcCtD
Vecuronium—Erythema—Carmustine—brain cancer	0.00708	0.0146	CcSEcCtD
Vecuronium—Nervous system disorder—Hydroxyurea—brain cancer	0.00701	0.0145	CcSEcCtD
Vecuronium—Skin disorder—Hydroxyurea—brain cancer	0.00694	0.0143	CcSEcCtD
Vecuronium—Erythema—Temozolomide—brain cancer	0.00684	0.0141	CcSEcCtD
Vecuronium—Hypersensitivity—Procarbazine—brain cancer	0.0068	0.0141	CcSEcCtD
Vecuronium—Angioedema—Temozolomide—brain cancer	0.00625	0.0129	CcSEcCtD
Vecuronium—ABCB1—gonad—brain cancer	0.00593	0.0115	CbGeAlD
Vecuronium—Cardiac disorder—Etoposide—brain cancer	0.00583	0.0121	CcSEcCtD
Vecuronium—Flushing—Etoposide—brain cancer	0.00583	0.0121	CcSEcCtD
Vecuronium—Rash—Procarbazine—brain cancer	0.00582	0.012	CcSEcCtD
Vecuronium—Dermatitis—Procarbazine—brain cancer	0.00582	0.012	CcSEcCtD
Vecuronium—ABCB1—pituitary gland—brain cancer	0.00579	0.0112	CbGeAlD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00578	0.012	CcSEcCtD
Vecuronium—Angiopathy—Etoposide—brain cancer	0.0057	0.0118	CcSEcCtD
Vecuronium—Immune system disorder—Etoposide—brain cancer	0.00568	0.0117	CcSEcCtD
Vecuronium—Mediastinal disorder—Etoposide—brain cancer	0.00567	0.0117	CcSEcCtD
Vecuronium—Tachycardia—Carmustine—brain cancer	0.00564	0.0117	CcSEcCtD
Vecuronium—ABCB1—medulla oblongata—brain cancer	0.00559	0.0108	CbGeAlD
Vecuronium—Anaphylactic shock—Temozolomide—brain cancer	0.00558	0.0115	CcSEcCtD
Vecuronium—Nervous system disorder—Temozolomide—brain cancer	0.00547	0.0113	CcSEcCtD
Vecuronium—Skin disorder—Temozolomide—brain cancer	0.00542	0.0112	CcSEcCtD
Vecuronium—Hypotension—Carmustine—brain cancer	0.0054	0.0112	CcSEcCtD
Vecuronium—Hypersensitivity—Hydroxyurea—brain cancer	0.00526	0.0109	CcSEcCtD
Vecuronium—ABCB1—midbrain—brain cancer	0.00511	0.00989	CbGeAlD
Vecuronium—ABCB1—spinal cord—brain cancer	0.00498	0.00965	CbGeAlD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00463	0.00957	CcSEcCtD
Vecuronium—Rash—Hydroxyurea—brain cancer	0.0045	0.00931	CcSEcCtD
Vecuronium—Dermatitis—Hydroxyurea—brain cancer	0.0045	0.00931	CcSEcCtD
Vecuronium—ABCB1—endocrine gland—brain cancer	0.00448	0.00868	CbGeAlD
Vecuronium—Anaphylactic shock—Etoposide—brain cancer	0.00447	0.00923	CcSEcCtD
Vecuronium—Urticaria—Temozolomide—brain cancer	0.00443	0.00917	CcSEcCtD
Vecuronium—ABCB1—head—brain cancer	0.00443	0.00857	CbGeAlD
Vecuronium—Tachycardia—Etoposide—brain cancer	0.00436	0.00901	CcSEcCtD
Vecuronium—Skin disorder—Etoposide—brain cancer	0.00434	0.00897	CcSEcCtD
Vecuronium—Hypersensitivity—Carmustine—brain cancer	0.00426	0.0088	CcSEcCtD
Vecuronium—Hypotension—Etoposide—brain cancer	0.00417	0.00863	CcSEcCtD
Vecuronium—Hypersensitivity—Temozolomide—brain cancer	0.00411	0.0085	CcSEcCtD
Vecuronium—ABCB1—central nervous system—brain cancer	0.00404	0.00783	CbGeAlD
Vecuronium—ABCB1—cerebellum—brain cancer	0.00395	0.00765	CbGeAlD
Vecuronium—Rash—Carmustine—brain cancer	0.00364	0.00753	CcSEcCtD
Vecuronium—Dermatitis—Carmustine—brain cancer	0.00364	0.00752	CcSEcCtD
Vecuronium—Urticaria—Etoposide—brain cancer	0.00355	0.00734	CcSEcCtD
Vecuronium—Rash—Temozolomide—brain cancer	0.00352	0.00728	CcSEcCtD
Vecuronium—Dermatitis—Temozolomide—brain cancer	0.00352	0.00727	CcSEcCtD
Vecuronium—Hypersensitivity—Etoposide—brain cancer	0.00329	0.0068	CcSEcCtD
Vecuronium—ABCB1—brain—brain cancer	0.00321	0.00621	CbGeAlD
Vecuronium—Rash—Etoposide—brain cancer	0.00282	0.00582	CcSEcCtD
Vecuronium—Dermatitis—Etoposide—brain cancer	0.00281	0.00582	CcSEcCtD
